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Purpose: The incidence of adolescent idiopathic scoliosis (AIS) has rapidly in-
creased, and with it, physician consultations and expenditures (about one and a half 
times) in the last 5 years. Recent etiological studies reveal that AIS is a complex ge-
netic disorder that results from the interaction of multiple gene loci and the environ-
ment. For personalized treatment of AIS, a tool that can accurately measure the pro-
gression of Cobb’s angle would be of great use. Gene analysis utilizing single 
nucleotide polymorphism (SNP) has been developed as a diagnostic tool for use in 
Caucasians but not Koreans. Therefore, we attempted to reveal AIS-related genes 
and their relevance in Koreans, exploring the potential use of gene analysis as a di-
agnostic tool for personalized treatment of AIS therein. Materials and Methods: A 
total of 68 Korean AIS and 35 age- and sex-matched, healthy adolescents were en-
rolled in this study and were examined for 10 candidate scoliosis gene SNPs. Re-
sults: This study revealed that the SNPs of rs2449539 in lysosomal-associated trans-
membrane protein 4 beta (LAPTM4B) and rs5742612 in upstream and insulin-like 
growth factor 1 (IGF1) were associated with both susceptibility to and curve severi-
ty in AIS. The results suggested that both LAPTM4B and IGF1 genes were impor-
tant in AIS predisposition and progression. Conclusion: Thus, on the basis of this 
study, if more SNPs or candidate genes are studied in a larger population in Korea, 
personalized treatment of Korean AIS patients might become a possibility.
Key Words:   Adolescent idiopathic scoliosis, gene, single nucleotide polymor-
phism
INTRODUCTION
Adolescent idiopathic scoliosis (AIS) is characterized by a structural lateral curvature 
of the spine with a rotary component deviation in otherwise healthy individuals. 
When defined as a Cobb’s angle of at least 10°, AIS is the most common pediatric 
spinal deformity, with reports of incidences ranging from 0.5% to 10% worldwide.1 
A report published in Korea revealed a scoliosis prevalence of 3.26% among 
1134890 school children, higher than those of other countries.2 According to a no-
tification released by the Korea Health Insurance Review and Assessment Service, 
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or exercise only often improve Cobb’s angle. In some cases, 
progression of deformity occurs rapidly, and physicians and 
their patients may miss the proper timing of surgery (Fig. 1). 
To solve this problem, a more accurate diagnostic tool is 
needed to determine whether or not deterioration will occur.
A prognostic test with a sufficient negative predictive val-
ue (NPV) can alter the monitoring schedule of a patient. 
Moreover, such test can reveal patients whose Cobb’s angle 
will not undergo serious progression. Accordingly, low risk 
patients with a definite NPV might be spared the long-term 
negative effects of repeated exposure to radiation, unneces-
sary treatments, emotional stress, cost of direct care (physi-
cian’s fee, hospital charge) and indirect cost of care, such as 
time away from a patient’s studies and hospital visit expens-
es.10,11 In those who might undergo serious progression, 
however, it is important that AIS does not get worse. An ef-
fective prognostic test would allow physicians to develop 
the number of scoliosis patients and expenditures related to 
its treatment increased by 12.2% and 40.3% over the past 
five years, respectively.3
AIS is usually noticed while bathing or during physical 
activity by a child’s parents. Sometimes, early detection of 
AIS occurs during periodic school screening upon discov-
ery of a waist or rib hump.4 The Adams forward bending 
test is helpful in detecting a thoracic rib hump or lateralized 
lifting of the buttock, but exact diagnosis is difficult. A hump 
and/or the Adams forward bending test are sensitive but not 
specific. Upon suspicion of AIS, radiographs can be used to 
confirm the diagnosis.
Clinical features and radiographic findings suggestive of 
minimal or mild idiopathic scoliosis do not adequately predict 
the future progression of the deformity. Even mild idiopathic 
scoliosis has been found to progress, so that regular medical 
assessment over a period of years has become necessary to 
detect and assess progression of the deformity.1,5,6 The current 
standards of care suggest that children and teens with AIS 
should be monitored until they cease growing, usually with 
serial radiographs, for curve progression. If serial radiographs 
confirm progression of Cobb’s angle (20<Cobb’s angle<45), 
a brace should be administered as the next step in the prima-
ry treatment thereof. Approximately 8% to 10% of all pa-
tients with adolescent idiopathic scoliosis are prescribed a 
brace at some point during their treatment. If the spinal curve 
continues to progress (Cobb >45), spinal fusion is often 
recommended. 
Brace treatment comprising wearing of a brace for a mini-
mum of 15 hours per day is considered effective. However, 
practically, it is difficult to ensure that adolescents wear a 
brace 15 hours a day.7 In order to overcome non compliance, 
electronic monitoring of these individuals is now followed 
in certain places.8 Due to difficulties faced during brace 
treatment, a prognostic method is direly needed to assess 
whether the deformity will progress or not. Such methods 
could help clinicians plan the treatment schedule of AIS on 
an individual and more effective manner. 
Factors known to predict curve progression include ma-
turity, curve size, and position of the curve apex. Progres-
sion equations have also been developed to quantify the 
risk of progression. Peterson and Nachemson9 used a meth-
od combining Risser sign, level of apex, presence of trunk 
imbalance, and chronological age to the aforementioned list 
of factors to predict curve progression. Although this meth-
od might be of some help to clinicians and patients, some 
patients do not follow this equation, and a short period brace 
Fig. 1. (A) A female patient (8 years 1 month) when first discovered in had a 
Cobb’s of 12.5 degrees. She was kept under observation but the Cobb’s an-
gle deteriorated to 27 degrees. Therefore, she was treated with brace and 
exercise. After 2 years and 4 months of non-surgical treatment, Cobb’s an-
gle improved to 11.4 degrees. (B) Female patient (8 years 5 month) when 
first diagnosed, had 27.5 degrees Cobb’s and was treated with brace and 
exercise but the Cobb’s angle deteriorated to 140 degrees. Finally, her sco-
liosis and pulmonary functions deteriorated enough to cause serious dan-
ger to her life.
A
B
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nese than Caucasians. Therefore, from a database of Japa-
nese SNPs, we selected SNPs for study with a minor allele 
frequency of more than 5%. Other controversial SNPs in 
Asian populations were also included for confirmation. 
Common SNPs in the genes of matrilin 1 (MATN1) and in-
sulin-like growth factor 1 (IGF1) are reported to be associat-
ed with AIS in Chinese, but studies to uncover candidate 
genes or marker SNPs for AIS in Koreans have yet to be 
performed. Furthermore, only one paper has reported on a 
relationship between AIS and osteoporosis in Korea,17 and 
the lack of data has limited the ability of physicians in Korea 
to personalize treatment of AIS, unlike Caucasian popula-
tions. The objective of this study was to reveal AIS-related 
genes and their relevance in Koreans, exploring the potential 
use of gene analysis as a diagnostic tool for personalized 
treatment of AIS therein. 
MATERIALS AND METHODS
　　　
Prior to conducting our study, we received Institutional Re-
view Board and Clinical Research Ethics Committee ap-
proval of our study protocols. A total of 68 Korean adoles-
cents (8-18 years of age), newly diagnosed with AIS at the 
authors’ institution, in addition to 35 age- and sex-matched, 
healthy adolescents were enrolled in our study after apply-
ing the exclusion criteria detailed below. Some of the healthy 
controls comprised students from the school where the au-
thors conducted the study. The following candidates were 
excluded: those with a history of congenital anomalies, neu-
romuscular diseases, endocrine disorders, skeletal dysplasia 
or connective tissue disorders, or mental retardation or men-
tal illness, as well as psychiatric patients on medication af-
new clinical protocols for managing high risk AIS patients. 
Genetic associations in AIS have been described for de-
cades.11 Recent etiologic studies revealed that AIS is a com-
plex genetic disorder that results from the interaction of 
multiple gene loci and the environment.12,13 Linkage studies 
of these families revealed multiple potential genetic loci, 
chromosomes 6, 9, 16 and 17, that may predispose individ-
uals to the condition.14 Several genes such as bone morpho-
genetic protein 4, interleukin-6, leptin, matrix metallopro-
teinase-3, melatonin 1B receptor (MTNR1B), etc., have 
been shown to be associated with a combinatorial effect.15 
Recently, Ward insisted that by using 53 gene marker SNPs 
known to be associated with AIS, a NPV greater than 99% 
could be obtained.5 
Ward, et al.5 also reported that these 53 SNPs were close-
ly associated with AIS severity. The odds ratios for 5 of 
these SNPs (rs2449539, rs1437480, rs448013, rs10493083, 
rs16945692) with severe scoliosis ranged from 0.35 to 1.28, 
as shown in Table 1. Based on their study, a diagnostic kit 
was developed that could predict the progression of Cobb’s 
angle and was sold commercially. Subsequently, several 
studies were carried out in Oriental countries concerning 
AIS candidate genes and SNP markers thereof.16 Sharma, et 
al.6 genotyped the SNPs of an additional chromosome, 
3p26.3, and tested replication in two follow-up case-control 
cohorts, obtaining stronger results when all three cohorts 
were combined (rs10510181 odds ratio of 1.49). In addition, 
other significant associations in their genome-wide associa-
tion study (GWAS) were discovered for SNPs (rs2222973) 
in the Down syndrome cell adhesion molecule (DSCAM) 
gene, which encodes for an axon guidance protein in the 
same structural class. 
Ethnically, Koreans are much more similar to the Japa-
Table 1. Selected SNP Markers in This Study
rs number Associate gene Region Odds ratio Reference
rs10510181 CHL1 Near, intergenic 1.49   6
rs2222973 DSCAM Intron 0.56   6
rs2449539 LAPTM4B Intron 0.35   5
rs1437480 FOXB1 Near, intergenic 0.32   5
rs448013 CBLN4 Near, intergenic 0.31   5
rs10493083 RRAGC Near, intergenic 0.30   5
rs16945692 BRIP1 Intron 1.28   5
rs1149048 MATN1 Near, intergenic 1.08 20
rs4753426 MTNR1B Upstream 0.94 20
rs5742612 IGF1 Upstream No report 20
CHL1, close homolog of L1; DSCAM, Down syndrome cell adhesion molecule; LAPTM4B, lysosomal-associated transmembrane protein 4B; FOXB1, fork-
head box protein B1; CBLN4, cerebellin 4 precursor; RRAGC, ras-related GTP binding C; BRIP1, fanconi anemia group J protein; MATN1, matrilin 1, carti-
lage matrix protein, MTNR1B, melatonin receptor 1B; IGF1, insulin-like growth factor 1; SNP, single nucleotide polymorphism.
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teocalcin and serum carboxy-terminal collagen crosslinks 
(CTX) levels in heparinized plasma were measured using a 
solid-phase, two-site chemiluminescent enzyme-labeled im-
munometric assay (Immulite Osteocalcin, Diagnostic Prod-
uct Corporation, Los Angeles, CA, USA). Additionally, se-
rum alkaline phosphatase (ALP) by radio immune essay 
(RIA) (Tandem-R Ostase, Beckman Coulter, Fullerton, CA, 
USA) and serum 25(OH)D3 levels by RIA using insulin-de-
pleted saline (Immunodiagnostic Systems Limited, Boldon, 
UK) were measured.17 The intra-assay and inter-assay vari-
ability for 25(OH)D3 were below 10%.17 
SNP marker selection 
Reviewing many papers, we selected for study the most sig-
nificant SNPs documented in the most recent genome-wide 
association studies, as well as other important studies. Two 
SNP markers (rs10510181, rs2222973) selected from Shar-
ma, et al.’s paper, 5 SNP markers (rs2449539, rs1437480, 
rs448013, rs10493083, rs16945692) from Ward, et al.’s pa-
per, and 3 SNP markers (rs1149048, rs4753426, rs5742612) 
from the aforementioned Chinese paper were selected. 
Genotyping method
Genotypes were screened via single base primer extension 
assay using an ABI PRISM SNaPShot Multiplex kit (Ap-
plied Biosystems, Foster City, CA, USA) according to the 
manufacturer’s recommendations. Briefly, genomic DNA 
flanking the SNPs of interest was amplified via polymerase 
chain reaction (PCR) with forward and reverse primer pairs 
(Table 2) and standard PCR reagents in a 10 microliter re-
action volume, containing 10 ng of genomic DNA, 0.5 pM 
of each oligonucleotide primer, 1 microliter of 10X PCR 
buffer, 250 M dNTP (2.5 mM each) and 0.25 units of i-
StarTaq DNA Polymerase (5 unit/µL) (iNtRON Biotech-
nology, Seongnam, Korea). The PCR conditions were as fol-
lows: 10 min at 95°C for 1 cycle, and 35 cycles at 95°C for 
30s, 60°C for 1 min, 72°C for 1 min, followed by 1 cycle of 
72°C for 10 min. After amplification, the PCR products were 
treated with 1 unit each of shrimp alkaline phosphatase 
(SAP) (USB Corporation, Cleveland, OH, USA) and exo-
nuclease I (USB Corporation, Cleveland, OH, USA) at 
37°C for 75 minutes and 72°C for 15 minutes to purify the 
amplified products. One micro liter of the purified amplifi-
cation products were added to a SNaPshot Multiplex Ready 
reaction mixture containing 0.15 pmols of genotyping prim-
er for primer extension reaction. The primer extension reac-
tion was carried out for 25 cycles at 96°C for 10 seconds, 
fecting bone metabolism. From the 68 patients in the scoli-
osis group, 33 patients with a Cobb’s angle between 10-40 
degrees allowing for non-surgical treatment were subdivid-
ed into a lower risk group, while 35 patients whose Cobb’s 
angle was more than 40 degrees were divided into the high 
risk group as they required surgery. 
Evaluation of scoliosis angle
Normal standing postero-anterior radiographs were taken 
for each AIS patient upon their first visit. Standard tech-
niques for measuring Cobb’s angle were used, and if more 
than one curve was discovered, the most severe curve was 
selected for measurement. A Cobb’s angle of less than 10 
degrees was considered normal. 
Anthropometric measurements
Anthropometric measurements were done about body height 
and weight. Calculation of height for patients was corrected 
by use of Bjure’s formula [Log y=0.011x-0.177, where y is 
the loss of trunk height (cm) due to a deformed spine and x 
is the greatest Cobb’s angle of the primary curve].17,18 Cal-
culation of body mass indices (BMIs) was done by dividing 
weight (kg) by uncorrected height squared (m2).17
Dual-energy X-ray absorptiometry
Lumbar spinal bone mineral density (LSBMD) and femoral 
neck BMD (FNBMD) of the non-dominant proximal fe-
mur were measured by dual-energy X-ray absorptiometry 
(XR-36; Norland Corp., Fort Atkinson, WI, USA). LSB-
MDs were measured at L1-L4 in the anterior-posterior 
view.17 There was no difficulty in measuring BMD in the 
control group and lower risk group, but severely rotated 
vertebrae made the measurements difficult in the high risk 
group. To minimize this problem, each spine of the high 
risk group was pre-scanned once, after which a reference 
line was drawn to join the highest points of the iliac crests, 
which usually passed between the third and fourth lumbar 
spinous processes. On that reference line, a rectangle was 
erected to include L2-L4, and this was defined as the scan 
area.17 As the standardized T score for adolescents has not 
yet been exactly defined in Korea, total bone mass was used 
for bone mineral density. 
Biochemical markers of bone turnover
Blood samples were collected between 8:00 and 10:00 a.m. 
after an overnight fast. Plasma and serum samples were ana-
lyzed in a routine laboratory using standard procedures. Os-
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priate. p-values <0.05 were considered significant for clini-
cal parameters such as BMI. 
The Hardy-Weinberg equilibrium was tested for each SNP 
in the patient and control groups using the chi-square test. 
The Hardy-Weinberg equilibrium principle states that genetic 
variation in a population will remain constant from one gen-
eration to the next in the absence of disturbing factors. Fre-
quency distributions of genotypes in patients and controls 
were compared using the chi-square test for each SNP stud-
ied. One-way ANOVA was used to compare Cobb’s angles 
among different genotypes. Inter-group comparisons were 
made using t-test, a p-value of <0.01 was considered signif-
icant in genotype or allele comparisons.
RESULTS
 
In this study, the following three groups were compared: 35 
subjects in the control group, 33 patients in the lower risk 
50°C for 5 seconds, and 60°C for 30 seconds. The reaction 
products were then treated with 1 unit of SAP at 37°C for 1 
hour and 72°C 15 minutes to remove excess fluorescent dye 
terminators. One microliter of the final reaction samples 
containing the extension products was then added to 9 mi-
croliters of Hi-Di formamide (ABI, Foster City, CA, USA). 
The mixture was incubated at 95°C for 5 min, followed by 
5 min on ice, and then analyzed by electrophoresis in an 
ABI Prism 3730xl DNA analyzer. Analysis was carried out 
using Gene Mapper software (version 4.0; Applied Biosys-
tems, Foster City, CA, USA). Table 3 shows the primer sets 
and Tm used for the SNaPshot assay.
Statistical analysis
Statistical analysis was performed using statistical package 
for social science (SPSS) software version 11.5 for Win-
dows (SPSS, Chicago, IL, USA). Data are expressed as the 
mean±standard deviation. Groups were compared using t-
test and analysis of variance (ANOVA), whenever appro-
Table 2. Primer Sets and Tm for the SNaPshot Assay
rs number Strand Primer sequence Tm
rs10510181 Forward
Forward primer TACTTTGGACCCCATTTAGA
60Reverse primer ATGAAGGCAGCTCATTTCT
Genotyping primer TGTGTAGGAATAGCAGAGGGTC
rs2222973 Forward
Forward primer CCCTACTGCCTCCTTATCTT
60Reverse primer TTGCAGAGAGAAGGGACTAA
Genotyping primer CTATTGTGGATGTCAGAAGTCCAG
rs2449539 Forward
Forward primer CCTGCCTATGTTTTGTAGGA
60Reverse primer TGTAAATGTGGATTCCCAAC
Genotyping primer TTACTGAAGCCTCCCTCTGAGACTC
rs1437480 Forward
Forward primer AGATCCTGCCTGGCTAAG
60Reverse primer GCCATTTAACCTCTCCTAGTC
Genotyping primer AGCTTCCCAGCTCAATCTT
rs448013 Forward
Forward primer GGTAGCAGTTCCTACAGTGC
60Reverse primer TTGTAACAAGGAGGAGAGAAA
Genotyping primer CAGATCTTTTGATTTGCATCTCATC
rs10493083 Forward
Forward primer GTACAAAGGGGTCACAAAAG
60Reverse primer TTCTATATCTCCACCCATTCTC
Genotyping primer CTTTTGGCCCTCTCTTCCAGTTTT
rs16945692 Forward
Forward primer AGAGGGGTGTGTTTATCCTT
60Reverse primer AGGAATTATTTGCAGTCGTG
Genotyping primer CCACCATACCTCATTCTCAGAGCTT
rs1149048 Forward
Forward primer AATGAAAACTAACTACGAACCTG
60Reverse primer CTAATGAGCGGAGAAGTGAC
Genotyping primer TGACGGCCAGGGCTGTGTCC
rs4753426 Forward
Forward primer CACCCTCAAATGTAACCACT
60Reverse primer TATTTCCACCAAAAGACCTG
Genotyping primer CAACATATTTGTGATTAATCCATGC
rs5742612 Forward
Forward primer CAGGCAGCCTAGTAGAAGAA
60Reverse primer GATGGGAGAGCAATTTTAGA
Genotyping primer GGTTCTAGGAAATGAGATCACACC
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in Table 4. No variations of statistical importance were ob-
served in genotype frequencies and allele frequencies of the 
eight promoter SNPs among the lower risk group, high risk 
group and controls in the Korean population, when the 
SNPs were studied independently (Table 4).
The lysosomal-associated transmembrane protein 4 beta 
(LAPTM4B) polymorphism (rs2449539) was found to be 
significantly different among the controls and lower risk 
and high risk groups. In comparison of the three groups in-
dividually, the frequency of TT genotype was most com-
mon in the high risk group, followed by the low risk group 
and control group, respectively (p=0.014). In contrast, the 
frequency of the TC genotype was most common in the 
control group, followed by the low risk group and high risk 
group, in that order (p=0.003). In comparison between two 
groups (controls versus AIS patient group), the frequency 
of TT genotype was most common in the AIS patients 
group (p=0.008). Similarly, the frequency of TC genotype 
was most common in the control group as compared to the 
AIS patients group (p=0.004). These results are summa-
rized in Fig. 2. 
Additionally, IGF1 polymorphism (rs5742612) was also 
found to be significantly different among the controls and 
the lower risk and high risk groups. In comparison of the 
three groups individually, the frequency of GG genotype 
was most common in the control group, followed by the 
low risk group and high risk group, in that order (p=0.010). 
group and 35 patients in the high risk group (Table 3). The 
mean Cobb’s angle for lower risk group patients was 25.8° 
(SD=7.6°) and 58.8° (SD=21.0°) for high risk group patients. 
Age, sex, height and weight had no statistical significant dif-
ference among the three groups. BMI was 20.1 (SD=3.5) in 
the control group, 19.3 (SD=2.0) in the low risk group and 
19.1 (SD=2.8) in the high risk group, and this mathematical 
variation was not statistically significant bone formation 
marker alkaline phosphatase (ALP) levels were 174.7 IU 
(SD=98.1) in the control group, 77.0 IU (SD=24.5) in the 
low risk group and 108.5 (SD=16.4) the in high risk group. 
Again, despite variation, its statistical value was question-
able. Also, differences in CTX, representative of the degree 
of bone destruction, and osteocalcin, a bone formation 
marker, were found to be statistically inconclusive. Mean 
lumbar spine and femur neck bone mineral density (FNB-
MD) in AIS patients tended to be lower than that in con-
trols, yet the difference failed to reach statistical signifi-
cance. Vitamin 25(OH)D3 levels were 19.0 ng/mL (SD=9.0) 
in the high risk group, 23.1 ng/mL (SD=8.2) in the lower 
risk group and 26.2 ng/mL (SD=8.2) in the control group, 
and vitamin D levels were shown to be significantly lower 
in the high risk group than those in the lower risk and con-
trol groups (p=0.019). 
Genotypes were shown to be in Hardy-Weinberg equilib-
rium. The distribution of the genotypes and alleles of the 
cases and controls for the ten promoter SNPs are presented 
Table 3. Baseline Characteristics of the Subjects
Characteristic Control
Scoliosis patients p value*
Low risk 
(0< Cobb’s angle <40)
High risk 
(Cobb’s angle >40)
Three groups† Two groups‡
Number [n (%)]      35 (34.0)      33 (32.0)      35 (34.0)
Age (yrs)   13.4 (3.1)   14.5 (3.1)   14.9 (6.3) 0.244 0.214
Sex [male; n (%)]        9 (25.06)        7 (19.4)        9 (25.0) 0.653   0.8321
Height (cm) 157.5 (15.4) 159.5 (8.6)§ 160.1 (6.8) 0.667 0.556
Weight (kg)   51.4 (15.1)   49.1 (6.7)   48.9 (8.5) 0.651 0.526
Body mass index (kg/m2)   20.1 (3.5)   19.3 (2.0)   19.1 (2.8) 0.367 0.168
25(OH)D3 (ng/mL)   26.2 (8.2)   23.1 (8.2)   19.0 (9.0) 0.019 0.035
CTX (ng/mL)     1.1 (0.6)     0.9 (0.5)     0.8 (0.5) 0.143 0.065
Osteocalcin (mg/mL)   72.7 (43.7)   65.3 (46.2)   53.4 (32.7) 0.270 0.241
Alkaline phosphatase (IU/L) 174.7 (98.1)   77.0 (24.5) 108.5 (16.4) 0.436 0.210
Lumbar spine BMD (g/cm2)    0.81(0.17)   0.78 (0.14)   0.76 (0.09) 0.093 0.174
Femoral neck BMD (g/cm2)   0.81 (0.13)   0.79 (0.10)   0.72 (0.09) 0.126   0.0725
Cobb’s angle (°)     0.0 (0.0)   25.8 (7.6)   58.8 (21.0) <0.000 <0.000
CTX, carboxy-terminal collagen crosslinks; BMD, bone mineral density.
*χ2 test or t-test were used where appropriate.
†Three groups: control group vs. high risk group vs. lower risk group.
‡Two groups: control group vs. scoliosis group.
§Corrected height using Bjure’s formula.
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(rs2449539) (p=0.002).
DISCUSSION
In Korea, AIS patients make about 100000 visits to physi-
cians annually, thereby incurring an expenditure of millions 
of dollars or even more, and this expenditure has increased 
steeply over the past five years (Fig. 1). Clinicians and pa-
tients need to be aware of the risk of curve progression as 
Between the two groups (controls versus AIS patient group), 
the frequency of GG genotype was most common in the 
control group (p=0.006). However, there was no significant 
difference in allele frequencies for one SNP (rs5742612) 
(p=0.059).
As shown in Table 4, two SNPs at rs2449539 (p=0.003) 
and rs5742612 (p=0.006) were found to exhibit significant 
associations with AIS in Koreans (p<0.01). The other 8 SNPs 
demonstrated no such significant associations. There was a 
significant difference in allele frequencies for one SNP 
Table 4. Frequency of Genetic Variations in Control and Scoliosis Patients
Associate  
  gene
SNP Control
Scoliosis patients
p value
Three groups* comparison Two groups† comparison
Low risk High risk
Codomi-
nant
Domi-
nant
Recessive
Codomi-
nant
Domi-
nant
Recessive Allele
CHL1 rs10510181
GG 15 (42.9) 14 (42.4) 14 (40.0)
0.981 0.967 0.895 0.964 >0.999 >0.999 0.965GA 15 (42.9) 14 (42.4) 17 (48.6)
AA   5 (14.3)   5 (15.2)   4 (11.4)
DSCAM rs2222973
TT 23 (65.7) 14 (42.4) 24 (68.6)
0.078 0.057 0.069 0.430 0.400 0.177 0.207TC 11 (31.4) 14 (42.4) 10 (28.6)
CC   1 (2.9)   5 (15.2)   1 (2.9)
LAPTM4B rs2449539
TT 13 (37.1) 19 (57.6) 27 (77.1)
0.014 0.003 0.219 0.008 0.004 0.177 0.002TC 18 (51.4) 13 (39.4)   7 (20.0)
CC   4 (11.4)   1 (3.0)   1 (2.9)
FOXB1 rs1437480
GG 12 (34.3) 13 (39.4)   7 (20.0)
0.440 0.198 0.912 0.757 0.657 0.731 0.875GA 19 (54.3) 17 (51.5) 25 (71.4)
AA   4 (11.4)   3 (9.1)   3 (8.6)
CBLN4 rs448013
GG 14 (40.0) 20 (60.6) 17 (50.0)
0.226 0.236 0.239 0.223 0.211 0.336 0.114GA 18 (51.4) 11 (33.3) 17 (50.0)
AA   3 (8.6)   2 (6.1)   0 (0.0)
RRAGC rs10493083
TT 19 (30.6) 20 (60.6) 23 (65.7)
0.914 0.620 0.912 0.678 0.403 0.731 0.363TC 12 (38.7) 10 (30.3)   9 (25.7)
CC   4 (40.0)   3 (9.1)   3 (8.6)
BRIP1 rs16945692
GG 11 (31.4)   8 (24.2) 12 (34.3)
0.462 0.651 0.297 0.279 0.825 0.145 0.286GA 19 (54.3) 16 (48.5) 13 (37.1)
AA   5 (14.3)   9 (27.3) 10 (28.6)
MATN1 rs1149048
GG 12 (34.3) 14 (42.4)   9 (25.7)
0.633 0.347 0.754 0.803 >0.999 0.620 0.750GA 14 (40.0) 13 (39.4) 18 (51.4)
AA   9 (25.7)   6 (18.2)   8 (22.9)
MTNR1B rs4753426
CC   3 (37.1) 19 (57.6) 18 (51.4)
0.447 0.221 0.618 0.243 0.145 >0.999 0.152CT 21 (60.0) 14 (42.4) 16 (45.7)
TT   1 (2.9)   0 (0.0)   1 (2.9)
IGF1 rs5742612
AA 17 (48.6) 19 (57.6) 20 (57.1)
0.055 0.698 0.010 0.011 0.412 0.006 0.059AG 12 (34.3) 13 (39.4) 15 (42.9)
GG   6 (17.1)   1 (3.0)   0 (0.0)
SNP, single nucleotide polymorphism; CHL1, close homolog of L1; DSCAM, Down syndrome cell adhesion molecule; LAPTM4B, lysosomal-associated 
transmembrane protein 4 beta; FOXB1, forkhead box protein B1; CBLN4, cerebellin 4 precursor; RRAGC, ras-related GTP binding C; BRIP1, fanconi anemia 
group J protein; MATN1, matrilin 1, cartilage matrix protein, MTNR1B, melatonin receptor 1B; IGF1, insulin-like growth factor 1.
*Three groups: control group vs. high risk group vs. lower risk group.
†Two groups: control group vs. scoliosis group.
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kit has been validated for whites only. Thus, Korean specif-
ic SNP tests should be developed to personalize the treat-
ment of AIS therein. 
In this study, the authors selected a control group that was 
age- and sex-matched, so that age and sex did not differ 
among the three groups compared. BMI was 20.1 (SD=3.5) 
in the control group, 19.3 (SD=2.0) in the lower risk group, 
19.1 (SD=2.8) in the high risk group and arithmetically low 
in the AIS patient group (lower+high risk group), but this 
difference was not statistically significant. Several authors 
reported that scoliotic girls had lower mean weight and a 
lower bone mineral status compared to those in the control 
population.24,25 Leptin along with soluble leptin receptor was 
shown to play an important role in the regulation of bone 
and energy metabolism in children. Liu, et al.25 insisted that 
leptin and soluble leptin receptor were abnormal and asso-
ciated with deranged growth and anthropometric pheno-
types in AIS girls. According to Liu’s study, abnormality of 
leptin receptor leads to lower BMI, and osteoporosis is ac-
companied by the possibility of scoliosis. Although our 
study did not show any variation of significance, increasing 
the sample size of the study population may help in estab-
lishing any correlation that may exist between decreased 
BMI and AIS. 
In the present study, vitamin 25(OH)D3 level was 26.2 
(SD=8.2) in the control group, 23.1 (SD=8.2) in the lower 
risk group and 19.0 (SD=9.0) in the high risk group, the dif-
ference of which was statistically significant in the surgical-
they make treatment decisions. Peterson and Nachemson’s9 
progression equation might be of some help to clinicians 
and patients who want to base their treatment on the risk of 
progression. But some patients do not follow this equation, 
and to solve this problem, a more accurate diagnosis and 
diagnostic tool that can predict whether or not deterioration 
will occur is needed.
Though AIS is thought to be multifactorial disorder, dif-
fering degrees of interaction between multiple factors de-
pend on linear and summation causality. Although AIS has 
been linked to multifactorial causes, genetic factors are 
considered the most important cause.
There are many reports about the supportive role of ge-
netic inheritance in the development of AIS. A meta-analy-
sis of different twin studies has been performed and found a 
concordance rate for AIS of 73% in monozygous twins ver-
sus 36% in dizygous twins.20 With recent advances of ge-
netic analysis techniques, many different gene loci linked to 
AIS is reported by family-linkage studies. Miller, et al.21 re-
ported that gene loci in the primary regions on chromo-
somes 6, 9, 16, and 17 and in the secondary regions on 
chromosomes 1, 3, 5, 7, 8, 11, 12, and 19, after scanning 
202 families and 1198 individuals, were linked to AIS in 
2005. Yet, other studies failed to achieve the same results, 
and instead, found other candidate genes. Therefore, it is 
hard to establish whether the etiology of AIS is due to sin-
gle gene or not.22,23 Recently, many genetic association stud-
ies with the candidate gene approach have been performed 
with the help of information gathered from the international 
HapMap project. In previous studies, the selection of candi-
date gene selection followed to prior knowledge of the ex-
pression of observed phenotypes in AIS and different SNPs 
studied with the case-only and case-control analysis. More 
recently, a more comprehensive explanation on the possible 
genes involved in the etiopathogenesis of AIS has been pre-
sented by GWASs of all SNPs in the genome. In the recent 
report of Ward, et al.,5 the comparison of a GWAS of 1.8 mil-
lion genetic markers was performed between 1200 AIS pa-
tients and 1500 controls. Their study found 202 markers as-
sociated to curve progression, and after further refinement, 
30 markers were reported as the most useful prognostic 
markers for curve progression. After verifying the results of 
this study, they launched the development of commercially 
available kit with a NPV greater than 99% for AIS-PT. 
However, there was an important limitation to their work; 
genotype frequencies for several of the SNP markers used 
in the AIS-PT kit vary by race. Accordingly, their AIS-PT 
Fig. 2. Reviewing the relation between rs2449539 SNP and the Cobb’s an-
gle, genotype TT was compared with the CC, TC type and a significant dif-
ference (p=0.0028) was found. Comparison between CC type and TT type 
also showed a significant difference (p=0.0071). SNP, single nucleotide 
polymorphism.
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frequencies of the remaining 4 SNPs between AIS patients 
and controls in the Korean population when the SNPs were 
studied independently. Similarly, the allele frequencies were 
comparable between cases and controls (Table 4). Thus, 
rs2449539 polymorphism of the LAPTM4B gene may be 
important to the complex genetic etiopathogenesis of AIS. 
Comparing Ward’s study and our study, there are lot of ge-
netic differences between Caucasians and Asians.5 Two Chi-
nese papers reported the associations of rs1149048 near 
MATN1, rs10488682 near MTNR1B and rs4753426 near in-
sulin-IGF1 with AIS in Chinese.30,31 However, these associa-
tions were not shown to exist in a Japanese population.19 With 
exception of rs5742612 SNP upstream IGF1, genotype and 
allele frequency of two SNPs between the three groups did 
not differ (p from 0.145 to 0.999). We found that allele A of 
rs5742612 was not significantly related with a predisposition 
to AIS (p=0.059), but individuals with genotype GG were 
shown to be at a lower risk of AIS in comparison to AA and 
AG (p=0.006). In our study, the SNPs of rs1149048 and 
rs4753426 exhibited no association with AIS predisposition 
in Koreans, nor did we find any association for these two 
SNPs with curve severity. However, the rs5742612 SNP in 
the upstream IGF1 gene was shown to be closely related 
with AIS in Koreans. Our result fell somewhere between 
those for Chinese and Japanese populations. 
There were some limitations to this study. The number of 
samples tested was relatively small, which diminishes the 
statistical power of the study and the possibility of detecting 
correlations. Further studies with a larger patient population 
are recommended. The association with other factors, such 
as the markers of bone metabolism and other candidate 
genes, should be tested.
In conclusion, this study provides evidence that the SNP 
rs2449539 in LAPTM4B and rs5742612 in upstream IGF1 
genes were associated with both susceptibility to and curve 
severity in AIS. Our results suggest that LAPTM4B and 
IGF1 may both be important to AIS predisposition and pro-
gression. Nevertheless, expanding our database by increas-
ing the study size so that more SNPs or candidate genes can 
be studied in the Korean population would prove immense-
ly beneficial in developing a SNP marker for AIS specifi-
cally designed for the Korean population. 
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ly treated, high risk group (p=0.019). The BMDs of the 
spine were 0.81 g/cm2 (SD=0.17) in the control group, 0.78 
(SD=0.14) in the lower risk group and 0.76 (SD=0.09) in 
the high risk group, a difference which tended to be lower in 
the high risk group, but was not statistically significant 
(p=0.093). Generalized low bone mass and osteopenia in the 
axial and peripheral skeleton have been described in patients 
with AIS.26,27 The precise mechanism of bone loss in these 
patients is unclear. Recently, many studies have reported 
that gene polymorphism is related to osteoporosis, but such 
results vary and are difficult to interpret.27,28 Once again by 
increasing the size of the study population, the relationship 
between osteoporosis and AIS may be established. 
In a previous GWAS, Sharma, et al.6 insisted that chromo-
some 3p26.3 SNPs in the proximity of the cell adhesion mole-
cule with homology to the L1CAM (CHL1) gene (rs10510181) 
as well as SNPs in the DSCAM gene (rs222973) that en-
codes for an axon guidance protein were strongly associat-
ed with AIS. The prevalence of the rs10510181 genotype 
was nearly the same as that in the control, lower risk and 
high risk groups of the present study. The prevalences of the 
rs2222973 genotype were 42.4% (TT), 42.4% (TC) and 
15.22% (CC). In particular, lower risk AIS patients more fre-
quently exhibited the TC genotype, but this was not signifi-
cant (p=0.057, 0.078). By studying SNPs, in particular 
rs2222973, in a larger population in Korea, we may be able 
to develop SNPs as race-specific markers of AIS in Koreans. 
Among the 53 SNPs reported by Ward, et al. we studied 
the following five SNPs: rs2449539, rs1437480, rs448013, 
rs10493083 and rs16945692. Except for the SNP rs2449539 
that encodes the LAPTM4B gene, genotype and allele fre-
quency between the three groups did not differ (p-values 
from 0.198 to 0.914). LAPTM4B is a protein that in hu-
mans is encoded by the LAPTM4B gene encoded on chro-
mosome 8q22, which has been extensively studied in cancer 
research.29 We found that allele T of rs2449539 involved a 
significant predisposition to AIS (p=0.002), and individuals 
with the TT genotype were at a higher risk for AIS, in com-
parison to TC and CC (p=0.08, 0.04). In this study, we iden-
tified that rs2449539 polymorphism in the LAPTM4B gene 
is associated with both susceptibility and disease progres-
sion in AIS. Accordingly, we concluded that the LAPTM4B 
gene may be important to disease predisposition and pro-
gression. Additionally, we also reconfirmed previous reports 
of ethnic differences in the association between AIS and 
rs2449539 polymorphism of the LAPTM4B gene. No sta-
tistically significant differences were found in the genotype 
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